Polypharmacy and quality of life in Yemeni cancer patients undergoing chemotherapy: A cross-sectional study

Sayida Al-Jamei, Haneen Al-ansi, Malak Albiel, Enas Al-Awadhi, Shaima Jihad, Amal Noman, Fadwa Alhayani, Rehab Alarhabi, Kelechi Elizabeth Oladimeji · 2026

Read Polypharmacy and quality of life in Yemeni cancer patients undergoing chemotherapy: A cross-sectional study by Sayida Al-Jamei, Haneen Al-ansi, Malak Albiel, Enas Al-Awadhi, Shaima Jihad, Amal Noman, Fadwa Alhayani, Rehab Alarhabi, Kelechi Elizabeth Oladimeji (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13618909.txt.

Description

Sayida Al-Jamei and eight colleagues measure medication burden and quality of life in Yemeni cancer patients on chemotherapy. Their cross-sectional study ran at the National Oncology Centre in Sana'a from December 2025 to February 2026. Two hundred thirty-four adults were interviewed and their records reviewed. Polypharmacy meant five or more non-cancer medications, a common situation because chemotherapy demands many supportive drugs.

The burden was near-universal: about ninety-five percent met the polypharmacy threshold and over half took ten or more non-cancer medicines. Average global quality of life sat below fifty on a hundred-point scale, with financial difficulty the worst-scoring problem, ahead of fatigue and pain. Surprisingly, heavier medication burden did not independently predict worse quality of life. Being female did, predicting both lower quality of life and higher medication use, while older age and illiteracy showed borderline links to poorer scores.

Catalog record

CREATORSayida Al-Jamei, Haneen Al-ansi, Malak Albiel, Enas Al-Awadhi, Shaima Jihad, Amal Noman, Fadwa Alhayani, Rehab Alarhabi, Kelechi Elizabeth Oladimeji
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13618909

Browse the full library · About the Tower of Babel